2. UroToday Home
  3. Video Lectures

CRPC with Bone Metastases Videos

CRPC with Bone Metastases
Changing the Mechanism of Action in The Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC) - Phillip Koo
June 24, 2020
Details
CRPC with Bone Metastases
Bone Health and Osteoclast Targeted Therapies in Advanced Prostate Cancer - Matthew Smith
May 1, 2020
Details
CRPC with Bone Metastases
Real-World Clinical Outcomes with Radium-223 in Metastatic Castration-resistant Prostate Cancer - Neal Shore
March 8, 2020
Details
CRPC with Bone Metastases
Implementing Prostate Cancer Working Group 3 Criteria in Clinical Trials- Michael Morris and Lawrence Schwartz
February 25, 2020
Details
CRPC with Bone Metastases
Bone Health Agents in Patients with Castrate-Resistant Prostate Cancer - Bertrand Tombal
January 16, 2020
Details
CRPC with Bone Metastases
Anti-resorptive Therapy to Reduce Skeletal-Related Events Risk in Men with Bone-Metastatic CRPC Presentation - Chris Parker
September 20, 2019
Details
CRPC with Bone Metastases
Sequencing Treatments in Metastatic Prostate Cancer - Evan Yu
May 10, 2019
Details
CRPC with Bone Metastases
Real World Treatment Experience with Radium-223 - Daniel George
May 3, 2019
Details
CRPC with Bone Metastases
Contemporary Treatment of Castration-Resistant Prostate Cancer (CRPC) - Fred Saad
July 9, 2019
Details
CRPC with Bone Metastases
Bone Health in Prostate Cancer - A Conversation with Neal Shore and Oliver Sartor
January 20, 2019
Details
CRPC with Bone Metastases
Prostate Cancer Osteomimicry in Circulating Tumor Cells in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) - Andrew Armstrong
July 31, 2018
Details
CRPC with Bone Metastases
Updates on Health-Related Quality-of-Life (HRQoL) analyses in GU Oncology - Cora Sternberg
July 24, 2018
Details
CRPC with Bone Metastases
The State of Nuclear Medicine in the Treatment of Prostate Cancer - Interview with Oliver Sartor
June 25, 2018
Details
CRPC with Bone Metastases
Imaging Modality and Recommendations Included in RADAR 3: Interview with Phillip Koo
June 4, 2018
Details
CRPC with Bone Metastases
Whole Body MRI Scanning and Disease Progression - Anwar Padhani
December 14, 2017
Details
CRPC with Bone Metastases
The Future of Targeted Alpha Therapy - Neal Shore
December 10, 2017
Details
CRPC with Bone Metastases
RADAR II Group Recommendations - The Role of Therapeutic Layering
November 24, 2017
Details
CRPC with Bone Metastases
Using Fluciclovine in the Recurrent Prostate Cancer Patient- David Schuster
August 21, 2017
Details
CRPC with Bone Metastases
Radium-223: From Bench to Bed-side, and the Future Directions for Targeted Alpha Therapy - Joe O'Sullivan
July 21, 2017
Details
CRPC with Bone Metastases
Therapeutic Layering in Optimizing Treatment for Patients With CPRC (RADAR II)- Phillip Koo
May 23, 2017
Details
CRPC with Bone Metastases
Bone Targeted Therapy with Zoledronate or Denosumab is Required in Men with mCRPC Responding to Anticancer Therapy - Noel Clarke
April 19, 2017
Details
CRPC with Bone Metastases
Debate: Bone Targeted Therapy with Zoledronate or Denosumab is Required in Men with mCRPC Responding to Anticancer Therapy. Yes! - Fred Saad
April 19, 2017
Details
CRPC with Bone Metastases
Bone Targeted Therapy with Zoledronate or Denosumab is Required in Men with mCRPC Responding to Anticancer Therapy - Cora Sternberg
April 18, 2017
Details
CRPC with Bone Metastases
Use of Radium-223 in Clinical Practice: a Radiation Oncologist's Experience - Daniel Spratt
November 8, 2016
Details
CRPC with Bone Metastases
Operationalization of Radium-223 Therapy for Bone Metastases - Eric Rohren
October 17, 2016
Details
CRPC with Bone Metastases
Eric Rohren on Radium-223 Therapy for Bone Metastases - State of the Art Lecture
August 2, 2016
Details
CRPC with Bone Metastases
Abiraterone Acetate and Radium-223 in Castrate-Resistant Prostate Cancer: Finding the Right Treatment at the Right Time - Charles Ryan
July 28, 2016
Details
CRPC with Bone Metastases
Cristina Nanni on Flucicovine F18 (FACBC) in Prostate Cancer - State of the Art Presentation
July 13, 2016
Details
CRPC with Bone Metastases
eRADicAte: A Study of Radium-223 with Abiraterone Acetate in Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases - Neal Shore
June 28, 2016
Details
CRPC with Bone Metastases
Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo
June 21, 2016
Details
CRPC with Bone Metastases
Detection of Metastatic Disease in Prostate Cancer: Past, Present, Future- Phillip Koo
April 21, 2016
Details
CRPC with Bone Metastases
Radiopharmaceuticals in Prostate Cancer - Stefano Fanti
April 1, 2016
Details
CRPC with Bone Metastases
Radium-223: Nuclear Medicine Perspective - Phillip Koo
February 12, 2016
Details
CRPC with Bone Metastases
Detection of Metastatic Disease: Review of the RADAR Group Recommendations - Phillip Koo
February 2, 2016
Details
CRPC with Bone Metastases
Radium-223 in an International Early Access Program (EAP): Effects of Concomitant Medication on Overall Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
January 18, 2016
Details
CRPC with Bone Metastases
Effects of concomitant use of abiraterone and/or enzalutamide with radium-223
October 2, 2015
Details
CRPC with Bone Metastases
Radium-223 For mCRPC: The Urologist Perspective - Neal Shore
September 7, 2015
Details
CRPC with Bone Metastases
The Art and Science of Treating CRPC with Bone Metastases - Charles Ryan
September 8, 2015
Details
CRPC with Bone Metastases
Radium-223 in an Early Access Program: Effects of Concomitant Medication on OS in mCRPC Patients - Thomas Keane
June 15, 2015
Details
CRPC with Bone Metastases
EBRT Use and Safety with Radium-223 in Patients with CRPC and Bone Metastases from ALSYMPCA - Oliver Sartor
April 13, 2015
Details
CRPC with Bone Metastases
Radium-223 Expanded Access Program with Abiraterone and Enzalutamide - Oliver Sartor
April 10, 2015
Details
CRPC with Bone Metastases
Effects of Ra-223 with Docetaxel vs. Docetaxel on PSA and Bone Alkaline Phosphatase - Charles Ryan
March 16, 2015
Details
CRPC with Bone Metastases
Use of Radium-223 for Symptomatic mCRPC with or without Prior Docetaxel - Oliver Sartor
November 14, 2014
Details
CRPC with Bone Metastases
Lower Tumor Burden Patient with Progression after Sipuleucel-T, then Treated with Radium-223
October 10, 2014
Details
CRPC with Bone Metastases
Radium-223 added to Abiraterone Acetate Treatment
October 1, 2014
Details
CRPC with Bone Metastases
mCRPC: Assessing Progression from Asymptomatic to Symptomatic Disease
September 30, 2014
Details
CRPC with Bone Metastases
Impact of Prior Docetaxel, Extent of Disease, and Prior Bisphosphonates on Hematologic Safety of Ra-223
September 22, 2014
Details
CRPC with Bone Metastases
Utility of Radium-223 in Advanced Prostate Cancer
August 6, 2014
Details
CRPC with Bone Metastases
Practical Application of Ra-223: Treating mCRPC
June 17, 2014
Details
CRPC with Bone Metastases
Effect of Ra-223 on Symptomatic Skeletal Events in mCRPC
June 17, 2014
Details
CRPC with Bone Metastases
mCRPC Patient Shared Decision-making
June 16, 2014
Details
CRPC with Bone Metastases
Quantified Bone Scan Response After Radium-223
June 3, 2014
Details
CRPC with Bone Metastases
Bone-targeted Therapies and Radiopharmaceuticals
March 20, 2014
Details
CRPC with Bone Metastases
Height-Based Dosing with Ra-223
February 1, 2014
Details
CRPC with Bone Metastases
Radium-223 in mCRPC
December 9, 2013
Details